Skip to main content

Table 4 The distribution of combinations of Arg399Gln of gene XRCC1 and T309G of gene MDM2 polymorphic markers in Kyrgyz women with BC and controls

From: The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females

XRCC1/MDM2 genotypes Cases, n (%) Controls, n (%) OR (95% CI) χ2
Arg399Arg/G309G 12 (10) 17 (17) Reference  
Arg399Arg/T309G 18 (15) 31 (30) 0.82 (0.32–2.11) 0.17/0.684
Arg399Arg/T309T 8 (7) 8 (8) 1.42 (0.42–4.84) 0.31/0.578
Arg399Gln/ G309G 14 (12) 8 (8) 2.48 (0.79–7.76) 2.48/0.115
Arg399Gln/ T309G 38 (32) 18 (18) 3.00 (1.18–7.56) 4.49/0.034
Arg399Gln/ T309T 16 (14) 8 (8) 2.83 (0.92–8.73) 3.37/0.066
Gln399Gln/ G309G 3 (3) 3 (3) 1.42 (0.24–8.26) 0.15/0.697
Gln399Gln/ T309G 6 (5) 6 (5) 1.42 (0.37–5.48) 0.26/0.613
Gln399Gln/ T309T 2 (2) 3 (3) 1.42 (0.17–11.51) 0.11/0.74
  1. OR odds ratio, CI confidence interval